
Cleveland-Cliffs reported a strong Q2 with EBITDA tripling to $286 million and Q3 guidance at $575 million, supported by government grants and contract wins for facility upgrades. However, operational execution and debt reduction have lagged expectations, limiting upside potential. The stock is rated 'Hold' as valuation appears full at 9.3x forward EV/EBITDA, with further gains dependent on sustained earnings beats, faster deleveraging, and strong guidance in the second half of the year.
Following Cleveland-Cliffs' mixed Q2 results and cautious outlook, its stock price on Pluang is currently USD 12.78, down 0.66% as of Oct 14, 2026 20:32 WIB. The company’s market cap stands at $7.34 billion, with shares trading between a 52-week low of $7.82 and a high of $16.18. Typical investors hold the stock for about 5 days on the platform, reflecting moderate trading interest.